Five NSU Researchers Present at World Stem Cell Summit

Five NSU researchers present at World Stem Cell Conference hosted by Nova Southeastern University

The World Stem Cell Summit & RegMed Capital Conference invited five faculty members from the NSU Cell Therapy Institute to present on their research related to advancing new approaches to cancer immunotherapy and regenerative medicine at the organization’s 12th annual meeting.

The summit is the largest interdisciplinary stem cell meeting in the world, featuring more than 250 prominent scientists, business leaders, investors, philanthropists, regulators, policy-makers, economic development officers, patient advocates and experts in law and ethics, presenting the latest scientific discoveries, commercial and innovation opportunities, legal and regulatory solutions, and best practices. The event attracted more than 1,200 attendees from 40 nations.

Presentations from the NSU Cell Therapy Institute included:

  • H. Thomas Temple, M.D., NSU senior vice president, translational research & economic development
    Focus: Recent advances in bone and cartilage regeneration achieved by novel stem cell therapies and new approaches to treating sarcoma cancers.
  • Richard Jove, Ph.D., director, NSU Cell Therapy Institute and co-chair, World Stem Cell Summit
    Focus: An overview of the various collaborative research projects at NSU including cancer immunotherapy and stem cell programs targeting vision restoration and heart disease.
  • Evren Alici, M.D., Ph.D., NSU visiting research professor from Karolinska Institutet
    Focus: Novel approaches to cancer immunotherapy with a focus on targeted T-cells and natural-killer cells.
  • Outi Hovatta, M.D, Ph.D., NSU visiting research professor from Karolinska Institutet
    Focus: Recent progress in the development of stem cells for disease models and therapies.
  • Karl-Henrik Grinnemo, M.D., Ph.D., NSU visiting research professor from Karolinska Institutet
    Focus: New insights into the differentiation of vital heart cells from stem cells for treatment of cardiovascular disease.

“Nova Southeastern University has positioned itself as an emerging center of excellence in stem cell research,” said Bernard Siegel, M.D., executive director, Regenerative Medicine Foundation and founder and co-chair of the Summit. “We are proud key opinion leaders from the NSU Cell Therapy Institute will be presenting at the summit, including NSU’s esteemed visiting research professors from Karolinska Institutet.”

NSU is poised to be at the forefront of pioneering cell-based biomedical research with its NSU Cell Therapy Institute, an international collaboration with prominent medical research scientists from Sweden’s world-renowned Karolinska Institutet.

The NSU Cell Therapy Institute is housed in the university’s newly opened $100 million, Center for Collaborative Research (CCR), one of the largest (215,000 square feet) and most advanced research facilities in Florida. Located on NSU’s Fort Lauderdale/Davie Campus, the CCR is equipped with wet and dry labs; state-of-the-art research equipment, including access to a high-performance computing environment; and other resources, such as Florida LambdaRail, a high-speed broadband service delivery network with connectivity throughout the nation.